A Novel Algorithm for Treating Chronic Total Coronary Artery Occlusion

Hiroyuki Tanaka1, Etsuo Tsuchikane2, Toshiya Muramatsu3

  • 1Kurashiki Central Hospital, Okayama, Japan.

Insights

Guidewire manipulation time is crucial for chronic total occlusion (CTO) percutaneous coronary intervention (PCI). This study suggests redefining CTO PCI strategy algorithms based on guidewire time and patient characteristics.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Guidewire manipulation time is an underutilized metric in chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
  • Current CTO PCI strategies may not fully incorporate procedural time-related data.
  • Optimizing guidewire use is essential for successful CTO PCI outcomes.

Purpose of the Study:

  • To develop an algorithm for CTO PCI strategies incorporating angiographic characteristics and guidewire manipulation time.
  • To analyze the impact of guidewire manipulation time on procedural success in CTO PCI.
  • To identify predictors of guidewire failure in different CTO PCI approaches.

Main Methods:

  • Analysis of 5,843 patients from the Japanese CTO-PCI expert registry (2014-2017).
  • Evaluation of CTO PCI strategies, procedural outcomes, and guidewire manipulation times.
  • Comparison of guidewire manipulation times between antegrade and retrograde approaches, and success/failure groups.

Main Results:

  • Overall guidewire and technical success rates were 92.8% and 90.6%.
  • Median guidewire manipulation time was significantly longer in cases of guidewire failure (176 min) versus success (56 min).
  • Predictors of antegrade guidewire failure (reattempt, CTO length ≥20 mm, no stump) did not predict failure after retrograde approach.

Conclusions:

  • Guidewire manipulation time is a significant factor in CTO PCI success.
  • Current CTO PCI strategy algorithms may require redefinition based on guidewire time and patient characteristics.
  • Further research into incorporating time-based metrics into CTO PCI algorithms is warranted.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
199
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
191
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
210
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
205
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
286
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
230